[The outcome of the living donor]

Maryvonne Hourmant1

  • 1Service de néphrologie et d'immunologie clinique, CHU de Nantes, 44093 Nantes cedex, France. maryvonne.hourmant@chu-nantes.fr

Nephrologie & Therapeutique
|December 18, 2007
PubMed

Insights

Living kidney donation carries an extremely low risk of morbi-mortality for donors. Long-term outcomes are favorable, with renal function maintained and mortality lower than the general population, though blood pressure monitoring is crucial.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Public Health

Context:

  • Living kidney donation is a critical procedure for end-stage renal disease patients.
  • Understanding donor risks and long-term outcomes is essential for ethical and safe donation practices.

Purpose:

  • To comprehensively review the morbi-mortality risks associated with living kidney donation.
  • To evaluate the long-term health status and renal function of kidney donors.

Summary:

  • The peri-operative mortality risk for living kidney donors is extremely low (0.03%), with severe complications occurring in 0.3-1% of cases.
  • Donors exhibit better long-term mortality than the general population, with renal function stabilizing around 75% of pre-donation levels.
  • While renal risks like proteinuria are low, post-nephrectomy hypertension requires careful blood pressure monitoring in predisposed individuals.

Impact:

  • Provides crucial data for informed consent and donor selection processes in living kidney donation.
  • Highlights the safety and long-term benefits of kidney donation, potentially encouraging more individuals to consider donation.
  • Emphasizes the importance of lifelong follow-up for kidney donors, particularly regarding cardiovascular health.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...